Clinical trial
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
NCT00218192 · Butler Hospital, Other · Completed
Key facts
| NCT number | NCT00218192 |
|---|---|
| Title | A Trial to Reduce Hepatitis C Among Injection Drug Users - 1 |
| Official title | A Trial to Reduce Hepatitis C Among Injection Drug Users |
| Lead sponsor | Butler Hospital, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HCV Negative Status, HCV Risk Behavior |
| Intervention type | Behavioral |
| Interventions | Behavior Therapy |
| Enrollment | 277 |
| Start date | Sep 1, 2000 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | May 22, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: